Steven Goodman
Publication Details
-
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
J Natl Cancer Inst. 2006; (14): 996-1004
The noninvasive identification of bladder tumors may improve disease control and prevent disease progression. Aberrant promoter methylation (i.e., hypermethylation) is a major mechanism for silencing tumor suppressor genes and other cancer-associated genes in many human cancers, including bladder cancer.
